Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Change in Accured Expenses (2016 - 2025)

Macrogenics (MGNX) has disclosed Change in Accured Expenses for 14 consecutive years, with -$1.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 138.01% to -$1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$916000.0, a 118.31% decrease, with the full-year FY2025 number at -$916000.0, down 118.31% from a year prior.
  • Change in Accured Expenses was -$1.8 million for Q4 2025 at Macrogenics, down from $8.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $8.6 million in Q3 2025 to a low of -$6.5 million in Q2 2025.
  • A 5-year average of -$57900.0 and a median of -$610000.0 in 2022 define the central range for Change in Accured Expenses.
  • Biggest YoY gain for Change in Accured Expenses was 717.28% in 2024; the steepest drop was 1169.79% in 2024.
  • Macrogenics' Change in Accured Expenses stood at -$865000.0 in 2021, then crashed by 414.91% to -$4.5 million in 2022, then skyrocketed by 176.07% to $3.4 million in 2023, then skyrocketed by 42.65% to $4.8 million in 2024, then plummeted by 138.01% to -$1.8 million in 2025.
  • Per Business Quant, the three most recent readings for MGNX's Change in Accured Expenses are -$1.8 million (Q4 2025), $8.6 million (Q3 2025), and -$6.5 million (Q2 2025).